Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Carl Zeiss and Asclepion bring together ophthalmology businesses to create new company

This article was originally published in Clinica

Executive Summary

Carl Zeiss is to take a majority stake in fellow German company Asclepion-Meditec, which it will then merge into its own ophthalmic equipment division to form Carl Zeiss Meditec. The new Jena-based company will be a world market leader in systems for ophthalmology, the companies say. Shares in Asclepion leapt 47% to E12.20 ($11.60) on the news.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074152

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel